1. Home
  2. SAVA vs FUSB Comparison

SAVA vs FUSB Comparison

Compare SAVA & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$1.99

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Logo First US Bancshares Inc.

FUSB

First US Bancshares Inc.

HOLD

Current Price

$14.80

Market Cap

86.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
FUSB
Founded
1998
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
86.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SAVA
FUSB
Price
$1.99
$14.80
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
620.4K
6.7K
Earning Date
01-01-0001
04-29-2026
Dividend Yield
N/A
1.86%
EPS Growth
N/A
N/A
EPS
N/A
0.64
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$10.47
52 Week High
$4.98
$15.99

Technical Indicators

Market Signals
Indicator
SAVA
FUSB
Relative Strength Index (RSI) 41.19 45.36
Support Level $1.81 $12.26
Resistance Level $2.29 $14.88
Average True Range (ATR) 0.13 0.24
MACD -0.01 -0.11
Stochastic Oscillator 3.93 12.66

Price Performance

Historical Comparison
SAVA
FUSB

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

Share on Social Networks: